| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.013 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0098 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |